Back pain treatment in post-menopausal osteoporosis with vertebral fractures.

Research output: Contribution to journalArticle

Abstract

Chronic back pain is frequent in osteoporotic patients with multiple fractures, and increases after subsequent findings of new vertebral fractures. Both acute and chronic back pain improve during pharmacological treatment for osteoporosis, but the efficicacy is different among drugs. Patients affected by osteoporosis treated with antiresorptive and anabolic agents have a reduced risk of new or worsening back pain, particularly with teriparatide therapy. Teriparatide reduces back pain and improves quality of life in post-menopausal osteoporosis with vertebral fractures more than other drugs.

Original languageEnglish
Pages (from-to)21-23
Number of pages3
JournalAging clinical and experimental research
Volume19
Issue number3 Suppl
Publication statusPublished - Jun 2007

Fingerprint

Postmenopausal Osteoporosis
Back Pain
Teriparatide
Chronic Pain
Osteoporosis
Bone Density Conservation Agents
Anabolic Agents
Therapeutics
Pharmaceutical Preparations
Quality of Life
Pharmacology

ASJC Scopus subject areas

  • Ageing

Cite this

Back pain treatment in post-menopausal osteoporosis with vertebral fractures. / Ulivieri, Fabio Massimo.

In: Aging clinical and experimental research, Vol. 19, No. 3 Suppl, 06.2007, p. 21-23.

Research output: Contribution to journalArticle

@article{4edd2d1719f04983befcb5a9a1e84b95,
title = "Back pain treatment in post-menopausal osteoporosis with vertebral fractures.",
abstract = "Chronic back pain is frequent in osteoporotic patients with multiple fractures, and increases after subsequent findings of new vertebral fractures. Both acute and chronic back pain improve during pharmacological treatment for osteoporosis, but the efficicacy is different among drugs. Patients affected by osteoporosis treated with antiresorptive and anabolic agents have a reduced risk of new or worsening back pain, particularly with teriparatide therapy. Teriparatide reduces back pain and improves quality of life in post-menopausal osteoporosis with vertebral fractures more than other drugs.",
author = "Ulivieri, {Fabio Massimo}",
year = "2007",
month = "6",
language = "English",
volume = "19",
pages = "21--23",
journal = "Aging clinical and experimental research",
issn = "1594-0667",
publisher = "Springer International Publishing AG",
number = "3 Suppl",

}

TY - JOUR

T1 - Back pain treatment in post-menopausal osteoporosis with vertebral fractures.

AU - Ulivieri, Fabio Massimo

PY - 2007/6

Y1 - 2007/6

N2 - Chronic back pain is frequent in osteoporotic patients with multiple fractures, and increases after subsequent findings of new vertebral fractures. Both acute and chronic back pain improve during pharmacological treatment for osteoporosis, but the efficicacy is different among drugs. Patients affected by osteoporosis treated with antiresorptive and anabolic agents have a reduced risk of new or worsening back pain, particularly with teriparatide therapy. Teriparatide reduces back pain and improves quality of life in post-menopausal osteoporosis with vertebral fractures more than other drugs.

AB - Chronic back pain is frequent in osteoporotic patients with multiple fractures, and increases after subsequent findings of new vertebral fractures. Both acute and chronic back pain improve during pharmacological treatment for osteoporosis, but the efficicacy is different among drugs. Patients affected by osteoporosis treated with antiresorptive and anabolic agents have a reduced risk of new or worsening back pain, particularly with teriparatide therapy. Teriparatide reduces back pain and improves quality of life in post-menopausal osteoporosis with vertebral fractures more than other drugs.

UR - http://www.scopus.com/inward/record.url?scp=40449142558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40449142558&partnerID=8YFLogxK

M3 - Article

C2 - 18180603

AN - SCOPUS:40449142558

VL - 19

SP - 21

EP - 23

JO - Aging clinical and experimental research

JF - Aging clinical and experimental research

SN - 1594-0667

IS - 3 Suppl

ER -